4//SEC Filing
Kennedy David 4
Accession 0001062993-22-002731
CIK 0001822691other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 7:32 PM ET
Size
10.1 KB
Accession
0001062993-22-002731
Insider Transaction Report
Form 4
Kennedy David
General Counsel & Secretary
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+235,992→ 235,992 totalExercise: $1.23Exp: 2031-03-25→ Common Stock (235,992 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+3,693→ 3,693 totalExercise: $1.23Exp: 2031-03-25→ Common Stock (3,693 underlying) - Award
Stock Option (Right to Buy)
2022-02-02+66,560→ 66,560 totalExercise: $2.61Exp: 2031-06-30→ Common Stock (66,560 underlying)
Footnotes (4)
- [F1]25% of the shares underlying the option vested or shall vest on July 17, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting August 17, 2021.
- [F2]This option was issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for a comparable option previously issued by such company.
- [F3]25% of the shares underlying the option vested on July 17, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting August 17, 2021.
- [F4]25% of the shares underlying the option vested or shall vest on June 30, 2021 and the remainder of the shares vested or shall vest in 36 equal monthly installments thereafter, starting July 30, 2022.
Issuer
GreenLight Biosciences Holdings, PBC
CIK 0001822691
Entity typeother
Related Parties
1- filerCIK 0001397111
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 7:32 PM ET
- Size
- 10.1 KB